A Buré

1.6k total citations
45 papers, 884 citations indexed

About

A Buré is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, A Buré has authored 45 papers receiving a total of 884 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 15 papers in Infectious Diseases and 14 papers in Pharmacology. Recurrent topics in A Buré's work include Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (13 papers) and Antimicrobial Resistance in Staphylococcus (10 papers). A Buré is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (13 papers) and Antimicrobial Resistance in Staphylococcus (10 papers). A Buré collaborates with scholars based in France. A Buré's co-authors include B. Pangon, A. Philippon, C Carbon, J M Vallois, Pierre Legrand, Vincent Jarlier, Patrice Courvalin, Guillaume Arlet, François Caron and Paul Geertsema and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Gene.

In The Last Decade

A Buré

42 papers receiving 824 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Buré France 14 433 312 270 249 145 45 884
K. Dornbusch Sweden 16 593 1.4× 305 1.0× 214 0.8× 306 1.2× 177 1.2× 47 1.1k
M E Erwin United States 15 303 0.7× 454 1.5× 355 1.3× 279 1.1× 67 0.5× 44 926
P. H. Lagrange France 13 376 0.9× 269 0.9× 251 0.9× 98 0.4× 144 1.0× 58 803
Michael A. Pfaller United States 18 299 0.7× 389 1.2× 471 1.7× 211 0.8× 74 0.5× 27 1.0k
Meridith E. Erwin United States 15 398 0.9× 293 0.9× 376 1.4× 370 1.5× 46 0.3× 44 887
Kathrine Dornbusch Sweden 14 370 0.9× 153 0.5× 242 0.9× 144 0.6× 139 1.0× 41 754
Tatiana Bogdanovich United States 17 522 1.2× 275 0.9× 391 1.4× 278 1.1× 175 1.2× 27 1.1k
Maria M. Traczewski United States 18 487 1.1× 253 0.8× 312 1.2× 232 0.9× 147 1.0× 42 924
N. Brenwald United Kingdom 18 709 1.6× 786 2.5× 411 1.5× 704 2.8× 67 0.5× 27 1.5k
Lynne Garrity-Ryan United States 15 473 1.1× 312 1.0× 323 1.2× 244 1.0× 206 1.4× 25 1.1k

Countries citing papers authored by A Buré

Since Specialization
Citations

This map shows the geographic impact of A Buré's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Buré with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Buré more than expected).

Fields of papers citing papers by A Buré

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Buré. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Buré. The network helps show where A Buré may publish in the future.

Co-authorship network of co-authors of A Buré

This figure shows the co-authorship network connecting the top 25 collaborators of A Buré. A scholar is included among the top collaborators of A Buré based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Buré. A Buré is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beaugerie, Laurent, A Buré, A M Deluol, et al.. (1996). Results of culture from colonoscopically obtained specimens for bacteria and fungi in HIV-infected patients with diarrhea. Gastrointestinal Endoscopy. 44(6). 663–666. 7 indexed citations
2.
Molina, Jean‐Michel, et al.. (1991). Clinical and Bacterial Features of Infections Caused by Streptococcus milleri. Scandinavian Journal of Infectious Diseases. 23(6). 659–666. 64 indexed citations
3.
Besnier, Jean‐Marc, C. Leport, A Buré, & J. L. Vildé. (1990). Vancomycin-aminoglycoside combinations in therapy of endocarditis caused byEnterococcus species andStreptococcus bovis. European Journal of Clinical Microbiology & Infectious Diseases. 9(2). 130–133. 7 indexed citations
4.
Gachot, Bertrand, Élisabeth Bouvet, A Buré, et al.. (1990). [HIV infection and "malignant" strongyloidiasis].. PubMed. 40(23). 2129–30. 1 indexed citations
5.
Legrand, Pierre, G. Fournier, A Buré, et al.. (1989). Detection of extended broad-spectrum beta-lactamases inEnterobacteriaceae in four French hospitals. European Journal of Clinical Microbiology & Infectious Diseases. 8(6). 527–529. 62 indexed citations
6.
Sougakoff, Wladimir, A Petit, Sylvie Goussard, et al.. (1989). Characterization of the plasmid genes blaT-4 and blaT-5 which encode the broad-spectrum β-lactamases TEM-4 and TEM-5 in Enterobacteriaceae. Gene. 78(2). 339–348. 76 indexed citations
7.
Thabaut, A, Marie Chanal, A Buré, et al.. (1989). [In vitro antibacterial effect of a new oral cephalosporin, cefixime. Results of a multicenter study].. PubMed. 37(5 Pt 2). 528–33. 2 indexed citations
8.
Buré, A, Pierre Legrand, Guillaume Arlet, et al.. (1988). Dissemination in five French hospitals ofKlebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam. European Journal of Clinical Microbiology & Infectious Diseases. 7(6). 780–782. 91 indexed citations
9.
Joly, Véronique, B. Pangon, J M Vallois, et al.. (1987). Value of antibiotic levels in serum and cardiac vegetations for predicting antibacterial effect of ceftriaxone in experimental Escherichia coli endocarditis. Antimicrobial Agents and Chemotherapy. 31(10). 1632–1639. 49 indexed citations
10.
Pangon, B., Véronique Joly, J M Vallois, et al.. (1987). Comparative efficacy of cefotiam, cefmenoxime, and ceftriaxone in experimental endocarditis and correlation with pharmacokinetics and in vitro efficacy. Antimicrobial Agents and Chemotherapy. 31(4). 518–522. 24 indexed citations
11.
Lévy‐Frébault, V., B. Pangon, A Buré, Christine Katlama, & C Marche. (1987). Mycobacterium simiae andMycobacterium avium-M.intracellulare MixedInfection inAcquired ImmuneDeficiency Syndrome. 1 indexed citations
12.
Wolff, Michel, A Buré, Pierre Legrand, et al.. (1986). Septicémie mortelle à Trichosporon sp chez 3 malades immunodéprimés.. La Presse Médicale. 15(25). 1201–1201. 3 indexed citations
13.
Rouveix, É., A Buré, B. Régnier, et al.. (1986). Experience with imipenem/cilastatin in the intensive care unit. Journal of Antimicrobial Chemotherapy. 18(Supplement_E). 153–160. 12 indexed citations
14.
René, E, C Marche, B. Régnier, et al.. (1985). [Digestive manifestations of the acquired immunodeficiency syndrome (AIDS): study in 26 patients].. PubMed. 9(4). 327–35. 7 indexed citations
15.
Milcent, René, et al.. (1984). Synthesis of new derivatives of 4‐amino‐2,4‐dihydro‐1,2,4‐triazol‐3‐one as potential antibacterial agents. Journal of Heterocyclic Chemistry. 21(6). 1769–1774. 54 indexed citations
16.
Dournon, E, et al.. (1983). Epidemiological Features of Legionnaires' Disease in the Paris Area. Zentralblatt für Bakteriologie Mikrobiologie und Hygiene 1 Abt Originale A Medizinische Mikrobiologie Infektionskrankheiten und Parasitologie. 255(1). 76–83. 6 indexed citations
17.
Bricaire, François, A Buré, Sebastian Metz, et al.. (1983). [Erysipelothrix rhusiopathiae endocarditis. A case report and review of the literature].. PubMed. 134(7). 656–8. 2 indexed citations
18.
Geslin, P., et al.. (1979). [Pneumococcal serotyping. Multicentric inventory in hospital. Years 1977-1978 (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 27(9). 571–8.
19.
Frottier, J, et al.. (1974). [Septicemia due to staphylococcus albus. Report of 14 personal cases].. PubMed. 50(5). 347–53. 1 indexed citations
20.
Buré, A, et al.. (1971). [Evoution of gentamicin resistance].. PubMed. 79(11). 467–70. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. Dornbusch Breakdown of academic impact, for papers by M E Erwin Breakdown of academic impact, for papers by P. H. Lagrange Breakdown of academic impact, for papers by Michael A. Pfaller Breakdown of academic impact, for papers by Meridith E. Erwin Breakdown of academic impact, for papers by Kathrine Dornbusch Breakdown of academic impact, for papers by Tatiana Bogdanovich Breakdown of academic impact, for papers by Maria M. Traczewski Breakdown of academic impact, for papers by N. Brenwald Breakdown of academic impact, for papers by Lynne Garrity-Ryan
Rankless by CCL
2026